Loading
Peak Processing Limited Stock: price and insider trades · Australia
1 insider bought €25k of shares over the last 90 days, the latest filed 14 Oct 2026.
Peak Processing Limited: what insiders have been doing
Every trade that managers of Peak Processing Limited disclose to ASX is tracked on this page. The company sits in the Health Care sector. Over the twelve months to 18 October 2026, 8 filings were filed, from 3 insiders.
Only purchases show up on the open market, 4 purchases in all worth €132k, filed by 2 insiders. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The buyers include 2 senior executives. Manik Pujara filed the largest purchase, €82k, on 1 July 2026, which represents 0.081% of the company's market value.
Compared with its exchange (2,222 companies, median 3 filings), a count of 8 filings is above the norm. Our records for Peak Processing Limited go back to 2026, with 4 purchases and no sales on the open market in total.
The data flag 1 purchase as part of a group of insiders buying within 30 days of each other. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase. The most recent open-market purchase was published on 14 October 2026, 3 days ago. Typically, a trade is published a median of 2 days after it takes place. The shorter that gap, the sooner other investors can see what insiders have done.
Other companies in the same sector with recent insider buying flagged by our signals: Anixa Biosciences Inc and Vivos Inc. Source: insider filings from ASX. Past trades are no guide to future returns.
Insider Decl.
8
Thresholds
n/a
Buy Volume
€132,163
4 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleManik Pujara3 buys
Unknown1 buy
Since the insiders bought
- -16.7%Entry A$0.02 · Close 15 Oct 2026 A$0.01
- Unknown-16.7%Entry A$0.02 · Close 15 Oct 2026 A$0.01
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2024FY ended June 2024 · cache
A$0.02
Analyst consensus
Income statement
RevenueA$29.4M
Gross profitA$17.5M59% margin
EBITDA-A$28.9M-98% margin
Net income-A$32.1M-62.6% margin
Valuation
Beta1.29
Balance sheet & cash
Market capA$21.4M
Total debtA$6.5M
Free Cash Flow-A$4.8M
Profitability & ownership
ROA-21.0%
% insiders31.0%
% institutions0.0%
Last declaration on 14 October 2026
Declarations8 total
2,500,000 shares@ A$0.0160.20% mcap52.9% of flowShareASXISIN AU0000442287ASX:2924-03148744-3A704170
Canonical exit: 11 Jan 2027 (T+90)
ShareASXASX:2924-03144975-3A703437
1 shares@ A$136,000.000.081% mcap100.0% of flowShareASXASX:2924-03106325-3A696378
Canonical exit: 27 Sept 2026 (T+90)
300,000 shares@ A$0.0170.0030% mcap100.0% of flowShareASXASX:2924-03106121-3A696338
Canonical exit: 28 Sept 2026 (T+90)
2,000,000 shares@ A$0.01810.18% mcap100.0% of flowShareASXISIN AU0000442287ASX:2924-03087521-3A692835
Canonical exit: 2 Aug 2026 (T+90)
8 of 8 declarations
About Peak Processing Limited
Peak Processing Limited is a company focused on the health and pharmaceutical sector, providing innovative solutions for the processing and distribution of pharmaceutical products. It is listed on the XASX market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
